Dova Pharmaceuticals announces management changes

|About: Dova Pharmaceuticals (DOVA)|By:, SA News Editor

Dova Pharmaceuticals (NASDAQ:DOVA) appoints David Zaccardelli, Pharm. D., as President and CEO.

In addition, Jason Hoitt, joins Dova as Chief Commercial Officer.

Previously, Dr. Zaccardelli served as the Acting CEO of Cempra Pharmaceuticals and at United Therapeutics as chief operating officer, chief manufacturing officer and executive vice president, pharmaceutical development and operations.

Prior to Dova, Mr. Hoitt served as Vice President and Head of U.S. sales at Insmed since 2017.

Subscribe for full text news in your inbox